Diabetes patients with cognitive problems, and taking dipeptidyl peptidase-4 (DPP-4) inhibitors, were found to have slower cognitive decline and less amyloid beta in their brains. These findings, published in Neurology, suggest that DPP-4 inhibitors may have a protective effect for patients with diabetes and dementia.
Endocrine-disrupting chemicals may be increasing the risk of diabetes, according to a review published in Advances in Pharmacology. The review suggests that environmental factors should be appreciated more in health policy approaches to tackle the disease.
New research, published in Cell Reports, indicates that suppressing GABA in the liver can restore insulin sensitivity in mouse models of diabetes.
A long-term study, presented at the recent European Congress of Endocrinology 2021, reports that women who have gestational diabetes are more likely to develop diabetes later in life.
Patients with type 2 diabetes who take the diabetes drug, metformin, may have a threefold decrease in mortality risk from COVID-19, according to a study published in Frontiers in Endocrinology.
According to a study published in the Lancet, metabolic surgery may be more effective at treating type 2 diabetes in the long term, than medications and lifestyle interventions.